UniSuper Management Pty Ltd

Position in ABT — Abbott Laboratories

CIK 1989400 MELBOURNE, VICTORIA, C3

Position in ABT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$52,504,432

-$529,551 QoQ

Shares Held

578,625

+12.0% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#216

of 2,959 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UniSuper Management Pty Ltd holds $111,907,541 across 8 Medical Devices names. ABT ranks #1 (46.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories This page	578,625	$52,504,432
2	BSX	Boston Scientific Corp	767,067	$32,738,419
3	SYK	Stryker Corp	38,003	$11,964,864
4	EW	Edwards Lifesciences Corp	64,797	$5,861,536
5	GEHC	GE HealthCare Technologies Inc.	51,940	$3,324,679
6	DXCM	Dexcom Inc	44,045	$2,966,430
7	ZBH	Zimmer Biomet Holdings, Inc.	18,170	$1,564,255
8	PODD	Insulet Corp	6,456	$982,926

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$52,504,432	578,625	+12.0%	Shares	Sole	2026-08-14
2026-03-31	$53,033,983	516,548	-11.2%	Shares	Sole	2026-05-11
2025-12-31	$72,856,636	581,504	-3.3%	Shares	Sole	2026-02-12
2025-09-30	$80,510,128	601,091	+7.9%	Shares	Sole	2025-10-31
2025-06-30	$75,737,440	556,852	+21.2%	Shares	Sole	2025-07-22
2025-03-31	$60,959,440	459,551	-17.4%	Shares	Sole	2025-05-15
2024-12-31	$62,896,851	556,068	+4.5%	Shares	Sole	2025-02-12
2024-09-30	$60,680,454	532,238	+44.1%	Shares	Sole	2024-11-14
2024-06-30	$38,379,781	369,356	+32.0%	Shares	Sole	2024-08-05
2024-03-31	$31,793,657	279,726	+7.0%	Shares	Sole	2024-05-13
2023-12-31	$28,769,216	261,372	-4.7%	Shares	Sole	2024-02-13
2023-09-30	$26,553,267	274,169	-1.1%	Shares	Sole	2023-11-13
2023-06-30	$30,221,325	277,209	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.